• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人眼组织和培养细胞中组成性和炎症介质调节的趋化因子表达

Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells.

作者信息

Silverman Matthew D, Zamora David O, Pan Yuzhen, Texeira Paul V, Baek Seung-Hee, Planck Stephen R, Rosenbaum James T

机构信息

Department of Ophthalmology, Casey Eye Institute, Oregon Health & Sciences University, Portland, Oregon 97201, USA.

出版信息

Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1608-15. doi: 10.1167/iovs.02-0233.

DOI:10.1167/iovs.02-0233
PMID:12657599
Abstract

PURPOSE

Fractalkine (FKN) is a dual-adhesion molecule-chemokine that plays a role in inflammation but has not been explored in the eye. In the current study, constitutive expression of FKN was identified in human iris and retina, and its regulation by various cytokines in endothelial cells (ECs) and stromal cells from human iris, retina, and choroid was investigated.

METHODS

Human iris and retina explants were evaluated for FKN mRNA and protein expression using RT-PCR and immunohistochemistry, respectively. Cultured ocular ECs and stromal cells were stimulated with various inflammatory mediators (endotoxin; TNFalpha; interferon-gamma; interleukin (IL)-1alpha, -4, -10, -13, -17, and -18; and/or CD40 ligand, or combinations thereof), with FKN mRNA being subsequently evaluated by cDNA array and/or RT-PCR and FKN protein by enzyme-linked immunoculture assay (ELICA) and/or by Western blot analysis.

RESULTS

Iris and retina explants constitutively expressed FKN protein in microvascular ECs and also in several stromal cell types. Iris and retina both express FKN mRNA. TNFalpha upregulated FKN in iris explants. All ocular microvascular ECs and stromal cultures expressed low FKN mRNA and/or protein levels, which were variably upregulated by endotoxin, TNFalpha, interferon-gamma, IL-1alpha, and/or CD40 ligand, but not by IL-18. In ECs, the Th2 cytokines IL-4 and -13, but not IL-10, reduced TNFalpha-induced FKN protein. IL-17, usually considered proinflammatory, reduced TNFalpha-induced FKN protein in ocular ECs.

CONCLUSIONS

FKN is expressed in various ocular tissues and cells. Inflammatory mediator modulation of ocular FKN expression suggests that this adhesive chemokine may play important roles in regulating leukocyte efflux in inflammatory eye diseases, such as anterior uveitis and retinochoroiditis.

摘要

目的

趋化因子(FKN)是一种双粘附分子趋化因子,在炎症中发挥作用,但尚未在眼部进行研究。在本研究中,在人虹膜和视网膜中鉴定出FKN的组成性表达,并研究了人虹膜、视网膜和脉络膜的内皮细胞(ECs)和基质细胞中各种细胞因子对其的调节作用。

方法

分别使用逆转录聚合酶链反应(RT-PCR)和免疫组织化学评估人虹膜和视网膜外植体中FKN mRNA和蛋白的表达。用各种炎症介质(内毒素;肿瘤坏死因子α(TNFα);干扰素γ;白细胞介素(IL)-1α、-4、-10、-13、-17和-18;和/或CD40配体,或其组合)刺激培养的眼部ECs和基质细胞,随后通过cDNA阵列和/或RT-PCR评估FKN mRNA,通过酶联免疫培养测定(ELICA)和/或蛋白质印迹分析评估FKN蛋白。

结果

虹膜和视网膜外植体在微血管ECs以及几种基质细胞类型中组成性表达FKN蛋白。虹膜和视网膜均表达FKN mRNA。TNFα上调虹膜外植体中的FKN。所有眼部微血管ECs和基质培养物均表达低水平的FKN mRNA和/或蛋白,其水平被内毒素、TNFα、干扰素γ、IL-1α和/或CD40配体不同程度地上调,但未被IL-18上调。在ECs中,Th2细胞因子IL-4和-13而非IL-10降低了TNFα诱导的FKN蛋白。通常被认为具有促炎作用的IL-17降低了眼部ECs中TNFα诱导的FKN蛋白。

结论

FKN在各种眼组织和细胞中表达。眼部FKN表达的炎症介质调节表明,这种粘附趋化因子可能在调节炎症性眼病(如前葡萄膜炎和视网膜脉络膜炎)中的白细胞外流中起重要作用。

相似文献

1
Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells.人眼组织和培养细胞中组成性和炎症介质调节的趋化因子表达
Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1608-15. doi: 10.1167/iovs.02-0233.
2
Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis.CX3C趋化因子、 fractalkine及其受体CX3CR1在实验性自身免疫性前葡萄膜炎中的表达
Mol Vis. 2005 Jul 1;11:443-51.
3
Fractalkine, a CX3C chemokine, as a mediator of ocular angiogenesis.趋化因子,一种CX3C趋化因子,作为眼部血管生成的介质。
Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5290-8. doi: 10.1167/iovs.07-0187.
4
Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses.趋化因子(CX3CL1)作为极化Th1反应的放大回路。
J Clin Invest. 2001 May;107(9):1173-81. doi: 10.1172/JCI11517.
5
Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.趋化因子通过CX3CR1和Jak Stat5信号通路上调内皮细胞中的细胞间黏附分子-1。
Circ Res. 2007 Nov 9;101(10):1001-8. doi: 10.1161/CIRCRESAHA.107.160812. Epub 2007 Sep 20.
6
Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis.趋化因子,类风湿关节炎及大鼠佐剂性关节炎中的一种新型趋化因子。
Arthritis Rheum. 2001 Jul;44(7):1568-81. doi: 10.1002/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1.
7
Fractalkine/CX3CL1 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-alpha and regulation by TGF-beta and corticosteroids.人气道平滑肌细胞产生趋化因子/ CX3CL1:由γ干扰素和肿瘤坏死因子-α诱导,转化生长因子-β和皮质类固醇调节
Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1230-40. doi: 10.1152/ajplung.00014.2004. Epub 2004 Aug 20.
8
The effect of Toxoplasma gondii infection on expression of chemokines by rat retinal vascular endothelial cells.弓形虫感染对大鼠视网膜血管内皮细胞趋化因子表达的影响。
J Neuroimmunol. 2005 Mar;160(1-2):41-7. doi: 10.1016/j.jneuroim.2004.10.023. Epub 2004 Dec 19.
9
Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions.在组成性和炎症条件下,CD16⁺单核细胞响应趋化因子进行跨内皮迁移。
Immunobiology. 2004;209(1-2):11-20. doi: 10.1016/j.imbio.2004.04.001.
10
Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.黏膜内皮细胞来源的趋化因子在炎症性肠病中对CX3CR1+ T细胞的募集增强
Gastroenterology. 2007 Jan;132(1):139-53. doi: 10.1053/j.gastro.2006.10.010. Epub 2006 Oct 12.

引用本文的文献

1
Role of CD4 T cell-derived cytokines in the pathogenesis of uveitis.CD4 T细胞衍生细胞因子在葡萄膜炎发病机制中的作用。
Clin Exp Med. 2025 Feb 5;25(1):49. doi: 10.1007/s10238-025-01565-7.
2
The Role of Fractalkine in Diabetic Retinopathy: Pathophysiology and Clinical Implications.趋化因子在糖尿病视网膜病变中的作用:病理生理学及临床意义
Int J Mol Sci. 2025 Jan 4;26(1):378. doi: 10.3390/ijms26010378.
3
Brief research report: ETS-1 blockade increases ICAM-1 expression in activated human retinal endothelial cells.简短研究报告:ETS-1阻断增加活化的人视网膜内皮细胞中细胞间黏附分子-1(ICAM-1)的表达。
Front Ophthalmol (Lausanne). 2024 Apr 16;4:1384428. doi: 10.3389/fopht.2024.1384428. eCollection 2024.
4
CX3CL1/CX3CR1 Signaling Mediated Neuroglia Activation Is Implicated in the Retinal Degeneration: A Potential Therapeutic Target to Prevent Photoreceptor Death.CX3CL1/CX3CR1 信号介导的神经胶质细胞激活与视网膜变性有关:预防光感受器死亡的潜在治疗靶点。
Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):29. doi: 10.1167/iovs.65.1.29.
5
Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy.增强 fractalkine/CX3CR1 信号通路可以通过减轻实验性糖尿病性视网膜病变中小胶质细胞的激活来减少神经炎症。
J Cell Mol Med. 2022 Feb;26(4):1229-1244. doi: 10.1111/jcmm.17179. Epub 2022 Jan 11.
6
Retinal Molecular Changes Are Associated with Neuroinflammation and Loss of RGCs in an Experimental Model of Glaucoma.视网膜分子变化与神经炎症和 RGCs 损失有关,在青光眼的实验模型中。
Int J Mol Sci. 2021 Feb 19;22(4):2066. doi: 10.3390/ijms22042066.
7
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases.趋化因子在风湿性疾病治疗中的新作用
Immunotargets Ther. 2020 Nov 4;9:241-253. doi: 10.2147/ITT.S277991. eCollection 2020.
8
A potential novel therapeutic target in diabetic retinopathy: a chemokine receptor (CCR2/CCR5) inhibitor reduces retinal vascular leakage in an animal model.在糖尿病性视网膜病变中一个新的潜在治疗靶点:趋化因子受体(CCR2/CCR5)抑制剂可减少动物模型中的视网膜血管渗漏。
Graefes Arch Clin Exp Ophthalmol. 2021 Jan;259(1):93-100. doi: 10.1007/s00417-020-04884-5. Epub 2020 Aug 20.
9
Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD).髓系来源的抑制细胞(MDSCs)在年龄相关性黄斑变性(AMD)中的潜在作用。
Front Immunol. 2020 Mar 20;11:384. doi: 10.3389/fimmu.2020.00384. eCollection 2020.
10
Retinal endothelial cell phenotypic modifications during experimental autoimmune uveitis: a transcriptomic approach.实验性自身免疫性葡萄膜炎期间视网膜内皮细胞表型改变:转录组学方法。
BMC Ophthalmol. 2020 Mar 17;20(1):106. doi: 10.1186/s12886-020-1333-5.